A nuclear reactor manufacturer that debuted on the Nasdaq in April 2026 with a valuation of roughly $11.9 billion. Its IPO was significantly oversubscribed, reflecting strong appetite for energy infrastructure.
Analysis of IPOs with upcoming clinical trial milestones?
These companies have recently gone public and are currently attracting significant investor interest: recent ipos to buy
If you are looking for the "next big thing," these "mega-unicorns" are widely expected to lead the IPO pipeline throughout the remainder of 2026:
Healthcare biotech; currently trading ~47% above its initial offering. A nuclear reactor manufacturer that debuted on the
The 2026 IPO market has opened with its strongest first quarter since 2021, driven by high demand for AI-related infrastructure and fintech. While many recent debuts have been volatile, several high-profile companies from 2025 and 2026 are showing strong fundamentals or have received bullish analyst ratings. 🚀 Top Recent IPOs to Watch
An electric vehicle startup that listed in early 2025 and saw massive year-to-date gains of ~132% by the end of that year. It recently received a "Buy" rating from HDFC Securities . 📉 Performance Snapshot: FTSE Renaissance US IPO Index These companies have recently gone public and are
AI responses may include mistakes. For financial advice, consult a professional. Learn more Best IPO Stocks to Buy in 2026: Latest Stocks to Watch